Long-Term Efficacy of Vismodegib After its Withdrawal and Patients' Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI)

• Main Authors: Alessia Villani (Author), Matteo Megna (Author), Gabriella Fabbrocini (Author), Milena Cappello (Author), Maria Antonietta Luciano (Author), Claudia Costa (Author), Massimiliano Scalvenzi (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2019-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction Although non-melanoma skin cancers (NMSCs) are associated with a very low mortality risk, they have been reported to have a major impact on patients' health-related quality of life (HRQoL). Vismodegib is a therapy for patients who are affected by locally advanced basal cel...